Literature DB >> 25180604

Mast cells aggravate sepsis by inhibiting peritoneal macrophage phagocytosis.

Albert Dahdah, Gregory Gautier, Tarik Attout, Frédéric Fiore, Emeline Lebourdais, Rasha Msallam, Marc Daëron, Renato C Monteiro, Marc Benhamou, Nicolas Charles, Jean Davoust, Ulrich Blank, Bernard Malissen, Pierre Launay.   

Abstract

Controlling the overwhelming inflammatory reaction associated with polymicrobial sepsis remains a prevalent clinical challenge with few treatment options. In septic peritonitis, blood neutrophils and monocytes are rapidly recruited into the peritoneal cavity to control infection, but the role of resident sentinel cells during the early phase of infection is less clear. In particular, the influence of mast cells on other tissue-resident cells remains poorly understood. Here, we developed a mouse model that allows both visualization and conditional ablation of mast cells and basophils to investigate the role of mast cells in severe septic peritonitis. Specific depletion of mast cells led to increased survival rates in mice with acute sepsis. Furthermore, we determined that mast cells impair the phagocytic action of resident macrophages, thereby allowing local and systemic bacterial proliferation. Mast cells did not influence local recruitment of neutrophils and monocytes or the release of inflammatory cytokines. Phagocytosis inhibition by mast cells involved their ability to release prestored IL-4 within 15 minutes after bacterial encounter, and treatment with an IL-4-neutralizing antibody prevented this inhibitory effect and improved survival of septic mice. Our study uncovers a local crosstalk between mast cells and macrophages during the early phase of sepsis development that aggravates the outcome of severe bacterial infection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25180604      PMCID: PMC4191002          DOI: 10.1172/JCI75212

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  56 in total

1.  Complete structure and expression in transfected cells of high affinity IgE receptor.

Authors:  U Blank; C Ra; L Miller; K White; H Metzger; J P Kinet
Journal:  Nature       Date:  1989-01-12       Impact factor: 49.962

Review 2.  Immunomodulatory mast cells: negative, as well as positive, regulators of immunity.

Authors:  Stephen J Galli; Michele Grimbaldeston; Mindy Tsai
Journal:  Nat Rev Immunol       Date:  2008-06       Impact factor: 53.106

Review 3.  Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease.

Authors:  Steven J Van Dyken; Richard M Locksley
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

4.  Novel role for mast cells in omental tissue remodeling and cell recruitment in experimental peritoneal dialysis.

Authors:  Mohammad Zareie; Paolo Fabbrini; Liesbeth H P Hekking; Eelco D Keuning; Piet M Ter Wee; Robert H J Beelen; Jacob van den Born
Journal:  J Am Soc Nephrol       Date:  2006-10-25       Impact factor: 10.121

5.  Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens.

Authors:  Anne Dudeck; Jan Dudeck; Julia Scholten; Anke Petzold; Sangeetha Surianarayanan; Anja Köhler; Katrin Peschke; David Vöhringer; Claudia Waskow; Thomas Krieg; Werner Müller; Ari Waisman; Karin Hartmann; Matthias Gunzer; Axel Roers
Journal:  Immunity       Date:  2011-06-24       Impact factor: 31.745

6.  Mast cell interleukin-10 drives localized tolerance in chronic bladder infection.

Authors:  Cheryl Y Chan; Ashley L St John; Soman N Abraham
Journal:  Immunity       Date:  2013-02-15       Impact factor: 31.745

7.  Immunodesign of experimental sepsis by cecal ligation and puncture.

Authors:  Daniel Rittirsch; Markus S Huber-Lang; Michael A Flierl; Peter A Ward
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

8.  IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities.

Authors:  Zane Orinska; Marcus Maurer; Farhad Mirghomizadeh; Elena Bulanova; Martin Metz; Natalia Nashkevich; Florian Schiemann; Jan Schulmistrat; Vadim Budagian; Julien Giron-Michel; Ernst Brandt; Ralf Paus; Silvia Bulfone-Paus
Journal:  Nat Med       Date:  2007-07-22       Impact factor: 53.440

9.  Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin.

Authors:  J R Gordon; S J Galli
Journal:  Nature       Date:  1990-07-19       Impact factor: 49.962

10.  Listeria monocytogenes alters mast cell phenotype, mediator and osteopontin secretion in a listeriolysin-dependent manner.

Authors:  Catherine E Jobbings; Hilary Sandig; Jayde K Whittingham-Dowd; Ian S Roberts; Silvia Bulfone-Paus
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

View more
  42 in total

Review 1.  Role of cellular events in the pathophysiology of sepsis.

Authors:  Chandra Bhan; Pankaj Dipankar; Papiya Chakraborty; Pranita P Sarangi
Journal:  Inflamm Res       Date:  2016-07-08       Impact factor: 4.575

2.  Lactic acid suppresses IgE-mediated mast cell function in vitro and in vivo.

Authors:  Daniel Abebayehu; Andrew J Spence; Heather Caslin; Marcela Taruselli; Tamara T Haque; Kasalina N Kiwanuka; Elizabeth Motunrayo Kolawole; Alena P Chumanevich; Scott A Sell; Carole A Oskeritzian; John Ryan; Sydney Ann Kee
Journal:  Cell Immunol       Date:  2019-04-12       Impact factor: 4.868

3.  Macrophage Subset Expressing CD169 in Peritoneal Cavity-Regulated Mucosal Inflammation Together with Lower Levels of CCL22.

Authors:  Dan Wang; Qiuting Li; Yang Yang; Shengyu Hao; Xiaolei Han; Jia Song; Yue Yin; Xiangzhi Li; Masato Tanaka; Chun-Hong Qiu
Journal:  Inflammation       Date:  2017-08       Impact factor: 4.092

4.  Mast cell-deficient mice Mcpt5Cre/Dicer fl/fl redefine the role of mast cells in experimental bullous pemphigoid.

Authors:  S Nsiah-Dosu; C Scholz; Z Orinska; C D Sadik; R J Ludwig; E Schmidt; D Zillikens; K Hartmann
Journal:  Skin Health Dis       Date:  2021-12-21

5.  Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1.

Authors:  Andriani C Patera; Anne M Drewry; Katherine Chang; Evan R Beiter; Dale Osborne; Richard S Hotchkiss
Journal:  J Leukoc Biol       Date:  2016-09-26       Impact factor: 4.962

6.  Vagal Regulation of Group 3 Innate Lymphoid Cells and the Immunoresolvent PCTR1 Controls Infection Resolution.

Authors:  Jesmond Dalli; Romain A Colas; Hildur Arnardottir; Charles N Serhan
Journal:  Immunity       Date:  2017-01-05       Impact factor: 31.745

7.  Phenotypic and functional alterations of peritoneal macrophages in lupus-prone mice.

Authors:  Gabriela Tejon; Nicolás Valdivieso; Felipe Flores-Santibañez; Verónica Barra-Valdebenito; Víctor Martínez; Mario Rosemblatt; Daniela Sauma; María Rosa Bono
Journal:  Mol Biol Rep       Date:  2022-02-24       Impact factor: 2.742

8.  Mast cell degranulation by a hemolytic lipid toxin decreases GBS colonization and infection.

Authors:  Claire Gendrin; Jay Vornhagen; Lisa Ngo; Christopher Whidbey; Erica Boldenow; Veronica Santana-Ufret; Morgan Clauson; Kellie Burnside; Dionne P Galloway; Kristina M. Adams Waldorf; Adrian M Piliponsky; Lakshmi Rajagopal
Journal:  Sci Adv       Date:  2015-07-17       Impact factor: 14.136

Review 9.  Revisiting mouse peritoneal macrophages: heterogeneity, development, and function.

Authors:  Alexandra Dos Anjos Cassado; Maria Regina D'Império Lima; Karina Ramalho Bortoluci
Journal:  Front Immunol       Date:  2015-05-19       Impact factor: 7.561

10.  C16, a novel sinomenine derivatives, promoted macrophage reprogramming toward M2-like phenotype and protected mice from endotoxemia.

Authors:  Ping Ni; Yue-Qin Liu; Jin-Yu Man; Wang Li; Shan-Shan Xue; Tao-Hong Lu; Zhao-Liang Su; Cheng-Lin Zhou
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.